Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2)
Conditions
Interventions
INOpulse®
Placebo
+1 more
Locations
23
United States
Arizona Pulmonary Specialists
Phoenix, Arizona, United States
University of California
Los Angeles, California, United States
University of California Davis Health
Sacramento, California, United States
University of Colorado Hospital
Aurora, Colorado, United States
University of Miami
Miami, Florida, United States
Avanza Medical Research Center
Pensacola, Florida, United States
Start Date
December 29, 2017
Primary Completion Date
November 22, 2019
Completion Date
December 1, 2023
Last Updated
February 28, 2023
NCT05746039
NCT06329401
NCT07073820
NCT06238622
NCT03854071
NCT06817590
Lead Sponsor
Bellerophon
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions